Robert Francomano

Robert Francomano is an experienced executive in the biopharmaceutical industry, having held the position of Chief Commercial Officer at multiple companies, including SynOx Therapeutics, SELLAS Life Sciences Group, Inc., and Stemline. In addition, Robert served as the Global Product Strategy Lead for Oncology at Baxalta and worked as a Strategic Consultant as a Senior Vice President in the Oncology sector. Robert's educational background includes Management Executive Education at the Massachusetts Institute of Technology and studies at The Wharton School.